Abstract
Four basic processes govern the concentrations toxicants achieve within vulnerable tissues – absorption, distribution, metabolism and excretion. These processes dictate the ‘toxicokinetic fate’ of a xenobiotic – describing how it penetrates cell barriers to enter tissues (i.e. absorption), whether it is dispersed to particular organs and tissue compartments (distribution), how it undergoes chemical transformation within the liver (metabolism) and whether the parent compound or its metabolites are permanently eliminated in urine, faeces or both (excretion). The behaviour of a xenobiotic during these processes is influenced by its basic physicochemical properties, including mass, charge and solubility in water and/or lipids. Study of the toxicokinetic fate of xenobiotics has confirmed the role of hundreds of xenobiotic-handling proteins – including enzyme catalysts and membrane transporters – in controlling the disposition of ingested chemicals. The possibility that one chemical might alter the ability of these proteins to metabolise or export another xenobiotic is also briefly considered (i.e. toxicant interactions).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Going Further
Birkett DJ. Pharmacokinetics made easy. Deakin: Australian Prescriber; 2009.
Ekroos M, Sjögren T. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc Nat Acad Sci (USA). 2006;103:13682–7.
Guengerich FP. Cytochrome P450 and chemical toxicology. Chem Res Toxicol. 2008;21:70–83.
Hukkanen J. Induction of cytochrome P450 enzymes: a view on human in vivo findings. Expert Rev Clin Pharmacol. 2012;5:569–85.
Josephy DP, et al. “Phase I and Phase II” drug metabolism: terminology that we should phase out? Drug Metab Rev. 2005;37:575–80.
Khojasteh SC, et al. Drug metabolism and pharmacokinetics quick guide. New York: Springer; 2011.
Lewis DF, Ito Y. Human CYPs involved in drug metabolism: structures, substrates and binding affinities. Expert Opin Drug Metab Toxicol. 2010;6:661–74.
Riddick DS, et al. NADPH–cytochrome P450 oxidoreductase: roles in physiology, pharmacology, and toxicology. Drug Metab Disp. 2013;41:12–23.
Smith DA, et al. Pharmacokinetics and metabolism in drug design. Weinheim: Wiley-VCH; 2012.
Staud F, et al. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics. Meth Mol Biol. 2010;596:199–222.
Zheng X, et al. Melamine-induced renal toxicity is mediated by the gut microbiota. Sci Transl Med. 2013;5(172):172ra22. doi:10.1126/scitranslmed.3005114.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Burcham, P.C. (2014). Toxicokinetics: The Behaviour of Chemicals in the Body. In: An Introduction to Toxicology. Springer, London. https://doi.org/10.1007/978-1-4471-5553-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5553-9_3
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5552-2
Online ISBN: 978-1-4471-5553-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)